Trial Profile
A Novel Compound for Alcoholism Treatment: A Translational Strategy - Part II
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 21 Mar 2022
Price :
$35
*
At a glance
- Drugs PF 5190457 (Primary)
- Indications Alcoholism
- Focus Therapeutic Use
- 23 Feb 2022 Status changed from completed to discontinued.
- 10 Sep 2020 Status changed from recruiting to completed.
- 25 Sep 2019 Planned End Date changed from 31 Dec 2019 to 31 Dec 2020.